Skip to main content

Streptococcus: Clinical Trials

Question for Department of Health and Social Care

UIN 71755, tabled on 9 July 2020

To ask the Secretary of State for Health and Social Care, what progress has been made on the Group B Streptococcus testing GBS3 trial; and when that trail is expecting to resume as covid-19 lockdown restrictions are eased.

Answered on

23 July 2020

As a result of the COVID-19 pandemic, some aspects of the GBS3 trial were stopped temporarily, including the randomisation of sites to the different arms of the trial and recruitment of participants. However, the team continued with other research related tasks to ensure smooth site opening for the trial re-start.

Training, randomisation and opening of sites to the trial requires the full engagement of maternity and microbiology services. The GBS3 trial hopes to randomise the first sites in September and begin recruiting women early in 2021 but this is dependent on the status of services at the time. The National Institute for Health Research (NIHR) has set out the Restart Framework to guide the restart of NIHR research activities which is available at the following link:

https://www.nihr.ac.uk/documents/restart-framework/24886